Experts meet to spur on New Zealand's hepatitis C elimination plan

AbbVie (NYSE: ABBV), has brought together leading local and international experts to discuss New Zealand’s progress towards the World Health Organization (WHO) 2030 goal for hepatitis C (HCV) elimination

Related Keywords

Australia ,Auckland ,New Zealand ,New Zealanders ,Zealand Abbvie ,Greg Dore ,Ted Gane ,Kylie Pennington ,World Health Organization ,University Of Auckland ,Us Center ,Kirby Institute ,Disease Analysis Foundation ,Ministry Of Health ,Professor Ed Gane ,Professor Gane ,Homie Razavi ,Professor Greg Dore ,Viral Hepatitis Clinical Research Program ,Professor Tim Dare ,Country Head ,New Zealand Abbvie ,